Compare LSTR & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LSTR | BIO |
|---|---|---|
| Founded | 1988 | 1952 |
| Country | United States | United States |
| Employees | N/A | 7450 |
| Industry | Trucking Freight/Courier Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.0B | 8.0B |
| IPO Year | 1994 | N/A |
| Metric | LSTR | BIO |
|---|---|---|
| Price | $206.42 | $294.26 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 4 |
| Target Price | $173.83 | ★ $339.75 |
| AVG Volume (30 Days) | ★ 433.4K | 321.9K |
| Earning Date | 04-28-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.95% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.16 | N/A |
| Revenue | ★ $4,743,760,000.00 | N/A |
| Revenue This Year | $6.89 | $2.74 |
| Revenue Next Year | $9.05 | $3.20 |
| P/E Ratio | $178.35 | ★ $9.72 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $119.40 | $236.73 |
| 52 Week High | $228.46 | $343.12 |
| Indicator | LSTR | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 50.35 | 53.05 |
| Support Level | $203.34 | $259.31 |
| Resistance Level | $228.46 | $314.39 |
| Average True Range (ATR) | 5.92 | 9.98 |
| MACD | -2.36 | 0.17 |
| Stochastic Oscillator | 16.41 | 66.60 |
Landstar System is an agent based asset-light third-party logistics provider focused on domestic truck brokerage. Historically, around half of its truck transportation freight is hauled by leased owner-operators with the remainder hauled by third-party broker-carriers. To a smaller degree, it offers intermodal, global air and ocean forwarding, and warehousing services. Landstar also runs a small business that offers insurance programs to captive owner-operators. It has a long history of industry-leading execution and operating profitability.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.